HEALTH● LOW3h ago · Oct 19, 2026, 11:45 AM
Marker Therapeutics Awarded $2 . 6 Million FDA Orphan Products Development Grant to Advance MT - 601 in Pancreatic Cancer
manilatimes.net · Philippines · north america
Marker Therapeutics received a multi-million dollar grant from the FDA for developing a treatment for pancreatic cancer. This grant supports advancements in treating a severe disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapPhilippines and nearby eventsMore from PhilippinesLatest stories and threat level
More from Philippines
SCI & TECH5h agoIs Philippines’ laws on underwater cables lagging behind its digital hub goal?South China Morning PostPOLITICS11h agoUnrest in Philippines threatens to upend US backed data centersResponsible StatecraftBUSINESS2d agoSolar power booms in Philippines as war on Iran spikes energy costsAl Jazeera [en]POLITICS2d agoPhilippines’ ‘China-free’ manufacturing strategy is a high-risk betSouth China Morning Post
More in Health
HEALTH47m agoNMA president condemns attacks on doctors, demands safe workplacesVanguard NigeriaHEALTH48m agoFlu cases are already increasing across the US. Is this year’s flu shot effective?The Independent WorldHEALTH1h agoUroGen gets FDA review for new bladder cancer therapySeeking Alpha TechHEALTH1h agoEwing Forum speakers offer insight , hope about Parkinson | Arts And Entertainmentfltimes.com · United States